Abstract Submission

Abstract submission is closed.

Instructions for Authors: Preparing and Submitting an Abstract

SUBMISSION OF ABSTRACTS: GENERAL GUIDELINES

Abstracts may be submitted for poster presentations. A limited number of accepted abstracts will also be selected for oral/podium presentation. Accepted abstracts will be published in a supplement issue of Toxicon.

Abstracts will be reviewed by the Organizing Committee on a rolling basis until the final abstract submission deadline. Abstract submitters can expect to receive notification regarding the acceptance of their abstract within 6 weeks of submission.

Abstracts must be submitted via the website. Only abstracts submitted via the online submission form will be sent to the Organizing Committee. Abstracts submitted by fax or e-mail will not be accepted.

Abstracts must be submitted in English.

Please contact the Secretariat at info@neurotoxins.org if you submitted an abstract but did not receive confirmation that it had been received.

Submission Checklist

Please ensure the following:

  1. Full contact information for the corresponding author and names of the co-authors are provided.
  2. The abstract is prepared in English.
  3. The character count of the abstract does not exceed 2000 characters including spaces (approximately 500 words). The character count does NOT include author information, title, footer or keywords. You may submit one chart or figure which also do not count towards the 2000 character count. Inclusion in the publication is subject to space limitations.
    A maximum of 6 keywords is permitted.

Abstracts must be uploaded to this website portal by clicking on the “Abstract Submit Button” shown below.
Abstracts deadline date to submit has been extended to Friday, 5 October, 2018.

Abstracts

The abstract should be concise and factual. Each abstract should briefly state the purpose of the research, the principal results, and major conclusions. Abstracts should be structured as follows:

Format Example for Structured  Abstracts (unstructured abstracts will also be accepted)

Title: BOLD & UPPERCASE

John Smitha,*, Jane Doeb
aNeurotoxin Institute, New York, NY, bHospital of Toxins

*Corresponding author: Neurotoxin Institute, 111 North Street, New York, 10004. E-mail address:  john.smith@xxx.com

Abstract title
Titles should be concise, specific, and informative, and should relate to the key points of the work.

Author names and affiliations
Information should include author name, affiliation, city, state/province/region, and country. To specify individual author information, use lower case letters of the alphabet sequentially next to the author’s name and corresponding author information. The author information should appear immediate after the author name listing.

Corresponding author contact information
Information should include: author name, affiliation, e-mail address, mailing address, city, state/province/region, zip /postal code, and country. The corresponding author should be indicated with an asterisk after his/her name in the listing of authors. The corresponding contact information should appear immediately after the line listing the authors’ information.

Introduction
Briefly state the precise objectives of the research or study question and explanatory background.

Methods
Clearly state the experimental methodology. Describe the study setting, basic design of the study, its duration, and the duration of follow-up. State the clinical disorder(s), important eligibility criteria, key sociodemographic features of patients, and number of participants. Explain the interventions (for clinical trials) or exposures (for observational trials).

Results
Results should be clear and concise. The main outcomes of the study should be reported and quantified, including baseline characteristics and final included/analyzed sample, along with confidence intervals or P values.

Conclusions
The main conclusions that are supported by the study should be presented indicating clinical or health policy implications.

Keywords
A maximum of 6 keywords should be provided immediately after the abstract to be used for indexing purposes. General and plural terms and multiple concepts should be avoided. Abbreviations should be used sparingly; only abbreviations firmly established in the field should be used.

Abbreviations
Abbreviations should be defined at their first mention in the text, and should be used consistently throughout the abstract.

Figures
Ensure that each illustration has a caption comprising a brief title and a description of the illustration. For pictures or images, accepted formats are jpg, gif, png, and pdf. Picture files should be saved to the smallest file size of acceptable visual quality.

Tables
Tables should be numbered consecutively in accordance with their appearance in the text and should carry a descriptive label.

Figures and tables should be called out next to the relevant text in the manuscript.

References
Every reference cited in the text should also appear in the reference list (and vice versa).

Reference Formatting
There are no strict requirements on reference formatting at submission. References can be in any style or format as long as the style is consistent. Where applicable, name(s) of author(s), journal/book title, chapter title/article title, year of publication, volume number/book chapter, and the page numbers must be present.

Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word appears the first time.

Use generic names of drugs. Express numbers as numerals.

Financial support of the research being published should be indicated.

Please see accompanying sample abstract for additional guidance. Submitted abstracts that do not comply with the required format will be returned for proper formatting.

Submission checklist

The following list will be useful during the final checking of an article prior to sending it to the journal for review.

Ensure that the following items are present:

One author has been designated as the corresponding author with contact details:

  • E-mail address
  • Full postal address

All necessary files have been uploaded, and contain:

  • Keywords
  • All figures with captions
  • All tables (including titles)

Further considerations

  • The abstract has been “spell-checked” and “grammar-checked”
  • All references mentioned in the reference list are cited in the text and vice versa
  • Permission has been obtained for the use of copyrighted material from other sources (including the Internet)


Poster Specifications

  • No larger than: Width: 94 cm  x Height: 124 cm  (3 ft. X 4 ft.)  (Portrait)
  • The International Neurotoxin Association will provide the boards to hang the posters on, as well as double-sided tape
  • Poster location and numbers will be received on site
  • Posters will be displayed for the duration of the conference.  You do not need to be present at your poster during the hours they are displayed
  • TOXINS 2019 posters will be posted on the conference website.  If you wish to have your poster included please send a high-quality PDF in advance.  You will receive QR codes onsite to affix to your poster

Image of Poster Shown Below

New Abstract Topic

International Forum: Exploring the National, Regional, and Local Clinical Experience With Botulinum Neurotoxins

In recognition of the country-specific and/or institution-specific differences in the use of BoNTs in clinical practice, this session is designed for clinicians and research scientists to share their experience and insights with global colleagues. A session format combining presentations and a panel discussion will identify and explore these differences in the clinical application of BoNTs relating to: patient populations, treatment protocols, best practices for common indications, pharmacoeconomic considerations, and data for the use of BoNT therapy in innovative ways.

You have Successfully Subscribed!

Cancellation policy:

60 days prior to arrival cancelled room nights will be subject to a 100% charge, equivalent to the full value, including any applicable VAT.

You have Successfully Subscribed!

Parking (Focus car park)

We offer the opportunity to pre-book parking in our enclosed section in the nearby Focus car park (Fabriksgatan 45) for 225 SEK/night (valid from 15:00 on the day of your arrival until 13:00 on the day of your departure).

The easiest way to pre-book is when you reserve a room or online via the link you receive in your confirmation or welcome e-mail from us 7 days before your arrival. Alternately, contact the reservations team by e-mail: room@gothiatowers.com or telephone: +46 (0)31-750 88 10.

If you have not pre-booked a parking space or you would like parking after hours, a space may be provided subject to availability. Please contact the Guest Service team at the hotel.

Swedish, Danish, and Norwegian cars:
If you have pre-booked and provided us with your car license number and a mobile phone number, you can drive directly to the Focus car park (Fabriksgatan 45) before checking in.

The car’s license plate will be scanned and the barrier will then open automatically for you at the entrance to the hotel’s enclosed section. The last six digits of your mobile number will be used as a code for the gate when you collect your car.

Cars from other countries, motorcycles, or cars with a personalised license plate:
Our system is unable to read these license plates, and you do not need to provide your license number. Instead, please collect a ticket from Guest Service before driving to the car park.

If you have not pre-booked parking, contact Guest Service when you arrive and they will help you to book a space, subject to availability.

You have Successfully Subscribed!

Share This